Barbara Nutzinger

Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Integrated epidemiological and molecular data inform the relationship between precancer and cancer states of esophageal adenocarcinoma.

Integrated epidemiological and molecular data inform the relationship between precancer and cancer states of esophageal adenocarcinoma.

Journal: Nature medicine
Published: November 11, 2025

A tumour-derived organoid biobank maps cancer gene dependencies.

A tumour-derived organoid biobank maps cancer gene dependencies.

Journal: Nature
Published: February 06, 2025

Integration of genomic aberrations to predict clinical outcomes for patients with gastroesophageal adenocarcinoma receiving neoadjuvant chemotherapy.

Integration of genomic aberrations to predict clinical outcomes for patients with gastroesophageal adenocarcinoma receiving neoadjuvant chemotherapy.

Journal: ESMO gastrointestinal oncology
Published: March 21, 2024

A decade of the Oesophageal Cancer Clinical and Molecular Stratification Consortium.

A decade of the Oesophageal Cancer Clinical and Molecular Stratification Consortium.

Journal: Nature medicine
Published: December 19, 2023

Mutational signature dynamics shaping the evolution of oesophageal adenocarcinoma.

Mutational signature dynamics shaping the evolution of oesophageal adenocarcinoma.

Journal: Nature communications
Published: February 13, 2023

Longitudinal tracking of 97 esophageal adenocarcinomas using liquid biopsy sampling.

Longitudinal tracking of 97 esophageal adenocarcinomas using liquid biopsy sampling.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 13, 2020

Corrigendum: A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.

Corrigendum: A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.

Journal: Genome research
Published: October 05, 2017

Corrigendum: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.

Corrigendum: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.

Journal: Nature genetics
Published: February 01, 2017

A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.

A comparative analysis of whole genome sequencing of esophageal adenocarcinoma pre- and post-chemotherapy.

Journal: Genome research
Published: August 23, 2016

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.

Journal: Nature genetics
Published: June 03, 2016
Showing 1-10 of 10

Last Updated: 09/26/2026